MedAdvisor Limited announced that it has executed an agreement with a top 10 pharmaceutical manufacturer and existing customer with a market capitalisation exceeding AUD 200 billion, to help educate under-vaccinated populations about the availability and benefits of COVID-19 vaccination. Demonstrates further traction with the new digital platform for the Adheris pharmacy network. This digital inMotion pilot program will launch in Fourth Quarter CY21 and the expected revenue totals up to USD 3 million (AUD 4 million). The program will be run through selected pharmacy chains that have been enabled for digital channel outreach. The highly scalable program is designed to target and educate certain demographics in states where COVID-19 vaccination rates are low MedAdvisor has signed a Statement of Work with an existing long-term customer to conduct a pilot of digital outreach to patient populations with low COVID-19 vaccination rates. The pilot is expected to be completed by the end of Second Quarter and revenues will be up to USD 3 million (AUD 4 million) dependent on the final number of patients reached. Assessment of the pilot is expected in early third quarter of fiscal year 2022. All material terms have been disclosed.